Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in androgenetic alopecia may be due to ongoing tiny inflammation and tissue changes around hair follicles.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Blocking the CXCL12–CXCR4 axis may help treat hair loss in alopecia.

Finasteride, dutasteride, and oral minoxidil are effective for treating hair loss, with spironolactone as an option for women.

Changes in scalp microbes may contribute to hair loss, suggesting new treatment options.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Mesenchymal stem cells show promise for hair regrowth in androgenetic alopecia, but more research is needed.

Plant-derived nanovesicles effectively deliver finasteride for hair regrowth in androgenetic alopecia.

Plant-based nanovesicles effectively deliver finasteride for hair regrowth in androgenetic alopecia.

Continuous use of finasteride and minoxidil is effective for treating androgenetic alopecia.

Androgenetic alopecia is common hair loss due to genetics and hormones, manageable with early treatment.

Herbal drugs show promise for treating alopecia with fewer side effects, but standardization is challenging.

Combining conventional and integrative treatments can help reduce hair loss and improve hair growth in women with androgenic alopecia.

The exact cause of male pattern baldness is unclear, but it may involve factors beyond androgens, offering new treatment possibilities.

Human amniotic stem cell exosomes may effectively treat hair loss by promoting hair regrowth.

High-frequency ultrasound effectively evaluates and diagnoses frontal fibrosing alopecia.

Combining anti-androgenic, anti-inflammatory, and anti-fibrotic treatments may improve hair loss outcomes.

Combining anti-androgenic, anti-inflammatory, and anti-fibrotic treatments may improve hair loss outcomes, but more testing is needed.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Blocking GPR91 can help prevent and reverse hair loss in androgenetic alopecia.

AGEs and their receptors play a significant role in hair loss by causing inflammation and oxidative stress.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

The internship highlighted the pharmacist's important role in health education and community engagement.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

Early diagnosis and treatment can help manage hair loss effectively.